OBJECTIVE: The carotid bodies (CBs) are peripheral chemoreceptor organs classically described as being O2 sensors, which are increasingly emerging as core players in metabolic control. Herein we evaluated CB activity in prediabetes patients and determined its correlation with dysmetabolism clinical features. DESIGN AND METHODS: Prediabetes patients were recruited at the Cardiology Service, Hospital Santa Marta, Centro Hospitalar Lisboa Central, EPE (CHLC-EPE). The study was approved by CHLC-EPE and NOVA Medical School Ethics Committee. Thirty-three prediabetic and 14 age-matched, non-prediabetic, volunteers had their peripheral chemosensitivity evaluated by the Dejours test. Serum biomarkers of metabolic disease, insulin sensitivity (HOMA-IR), blood pressure, carotid intima-media thickness (cIMT) and glucose tolerance were assessed. RESULTS: CB chemosensitivity was significantly increased in prediabetic group (P < 0.01). Fasting blood, glucose intolerance, fasting insulin and HOMA-IR were significantly higher in prediabetes patients. Insulin resistance correlated both with peripheral chemosensitivity, assessed by the Dejours test (P < 0.05) and with abdominal circumference (P < 0.01). HbA1c correlated with HOMA-IR (P < 0.05) and left cIMT (P < 0.05) in prediabetes patients. CONCLUSIONS: We conclude that CB is overactive in prediabetes subjects and that peripheral chemosensitivity correlates with fasting insulin and insulin resistance representing a novel non-invasive functional biomarker to forecast early metabolic disease.
OBJECTIVE: The carotid bodies (CBs) are peripheral chemoreceptor organs classically described as being O2 sensors, which are increasingly emerging as core players in metabolic control. Herein we evaluated CB activity in prediabetes patients and determined its correlation with dysmetabolism clinical features. DESIGN AND METHODS: Prediabetes patients were recruited at the Cardiology Service, Hospital Santa Marta, Centro Hospitalar Lisboa Central, EPE (CHLC-EPE). The study was approved by CHLC-EPE and NOVA Medical School Ethics Committee. Thirty-three prediabetic and 14 age-matched, non-prediabetic, volunteers had their peripheral chemosensitivity evaluated by the Dejours test. Serum biomarkers of metabolic disease, insulin sensitivity (HOMA-IR), blood pressure, carotid intima-media thickness (cIMT) and glucose tolerance were assessed. RESULTS: CB chemosensitivity was significantly increased in prediabetic group (P < 0.01). Fasting blood, glucose intolerance, fasting insulin and HOMA-IR were significantly higher in prediabetes patients. Insulin resistance correlated both with peripheral chemosensitivity, assessed by the Dejours test (P < 0.05) and with abdominal circumference (P < 0.01). HbA1c correlated with HOMA-IR (P < 0.05) and left cIMT (P < 0.05) in prediabetes patients. CONCLUSIONS: We conclude that CB is overactive in prediabetes subjects and that peripheral chemosensitivity correlates with fasting insulin and insulin resistance representing a novel non-invasive functional biomarker to forecast early metabolic disease.
Authors: Adriana M Capucho; Ana Chegão; Fátima O Martins; Hugo Vicente Miranda; Sílvia V Conde Journal: Nutrients Date: 2022-03-29 Impact factor: 5.717
Authors: Elena Stocco; Maria Martina Sfriso; Giulia Borile; Martina Contran; Silvia Barbon; Filippo Romanato; Veronica Macchi; Diego Guidolin; Raffaele De Caro; Andrea Porzionato Journal: Front Physiol Date: 2021-04-15 Impact factor: 4.566
Authors: Hong Peng Li; Hai Qin Wang; Ning Li; Liu Zhang; Shi Qi Li; Ya Ru Yan; Huan Huan Lu; Yi Wang; Xian Wen Sun; Ying Ni Lin; Jian Ping Zhou; Qing Yun Li Journal: Nat Sci Sleep Date: 2021-04-21
Authors: Andrea Porzionato; Aron Emmi; Elena Stocco; Silvia Barbon; Rafael Boscolo-Berto; Veronica Macchi; Raffaele De Caro Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-08-05 Impact factor: 5.464
Authors: Joana F Sacramento; Kryspin Andrzejewski; Bernardete F Melo; Maria J Ribeiro; Ana Obeso; Silvia V Conde Journal: Int J Mol Sci Date: 2020-08-03 Impact factor: 5.923